CHUEF(CHUEF)
CHUEF
No analyst ratings available
No analyst price targets available for CHUEF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $3.84T | $3.88T | $3.85T | $3.56T | $3.56T |
| Low | $3.62T | $3.67T | $3.63T | $3.37T | $3.37T |
| High | $4.06T | $4.08T | $4.06T | $3.76T | $3.76T |
| EBITDA Avg | $726.79B | $733.38B | $727.38B | $673.93B | $673.97B |
| Low | $684.68B | $694.69B | $687.13B | $636.64B | $636.67B |
| High | $767.62B | $772.41B | $767.17B | $710.79B | $710.83B |
| EBIT Avg | $614.81B | $620.38B | $615.31B | $570.09B | $570.13B |
| Low | $579.18B | $587.66B | $581.26B | $538.55B | $538.58B |
| High | $649.35B | $653.41B | $648.97B | $601.27B | $601.31B |
| Net Income Avg | $174.60B | $224.35B | $233.60B | $243.55B | $253.13B |
| Low | $162.04B | $208.21B | $216.80B | $226.03B | $234.92B |
| High | $187.02B | $240.30B | $250.21B | $260.87B | $271.13B |
| EPS Avg | $231.15 | $297.01 | $309.26 | $322.43 | $335.11 |
| Low | $214.52 | $275.64 | $287.01 | $299.23 | $311.00 |
| High | $247.58 | $318.12 | $331.25 | $345.35 | $358.94 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 4 / 1 | 3 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $1.01T | $875.01B | $980.58B |
| Low | $979.66B | $850.61B | $951.34B |
| High | $1.04T | $899.41B | $1.01T |
| EBITDA Avg | $191.33B | $165.51B | $185.48B |
| Low | $185.30B | $160.89B | $179.94B |
| High | $197.35B | $170.12B | $191.01B |
| EBIT Avg | $161.85B | $140.01B | $156.90B |
| Low | $156.75B | $136.10B | $152.22B |
| High | $166.95B | $143.91B | $161.58B |
| Net Income Avg | $47.67B | $42.69B | $63.69B |
| Low | $45.82B | $41.03B | $61.22B |
| High | $49.52B | $44.34B | $66.16B |
| EPS Avg | $63.11 | $56.51 | $84.31 |
| Low | $60.66 | $54.32 | $81.04 |
| High | $65.55 | $58.70 | $87.58 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |